PanGenex Corporation Finalizes Acquisition of Calgenex Corporation

TAMPA, Fla.--(BUSINESS WIRE)--PanGenex Corporation (Pink Sheets:PGXC) announces that on April 8th, 2008, the Company completed the acquisition of Calgenex Corporation. Calgenex develops and markets proprietary formulations to address specific health conditions. Calgenex has developed a line of nutraceuticals including Calci-CLEAR™ to address soft tissue calcification, Omeganol to encourage cholesterol balancing and the topical application Dermalleve for psoriasis, eczema and dermatitis.